Event Highlight: Rare Neurology Meets Global Policy during the 12th Congress of the European Academy of Neurology The meeting was chaired by Prof. Sameer Zuberi, EBC President-Elect. 1. Purpose & Strategic Framing The EAN 2026 side event convened global policy representatives, scientific societies, clinicians, patient advocates, researchers and industry stakeholders [...]
On 24 June, the European Parliament hosted the high-level policy debate "Future of the Younger Generation: How to Curb the Addiction Epidemic and Protect Europe's Brain Capital", bringing together policymakers, clinicians, researchers and civil society representatives to discuss the growing impact of nicotine addiction on youth mental health and brain development. Hosted by MEP [...]
The European Brain Council (EBC) is pleased to launch the Rethinking Myasthenia Gravis (MG) Policy Brief, a key outcome of the two-year Rethinking Myasthenia Gravis project. Launched during EBC’s Rare Disease Day event "Towards a Rare Brain Disease Ecosystem" in 2025, the project brings together researchers, clinicians, patient representatives, policymakers, and European Reference Networks [...]
Registration is now open for the 5th edition of the Brain Days at the United Nations General Assembly, set to take place on 23rd and 24th of September in New York City. Taking place on the sidelines of the 81st United Nations General Assembly (UNGA81) during the High Level Week, the Brain Days 2026 [...]
Building on the momentum of the Poland Country Profile and Denmark Country Profile, the Rethinking Schizophrenia initiative now turns its focus to Germany, examining how national policy can support more integrated, person-centred schizophrenia care. The Germany Country Profile builds on discussions from a Germany-focused webinar held on 4 March 2026, organised by the European [...]
The European Brain Council (EBC) warmly welcomes the publication of the S7 Academies Joint Statement “Advancing Brain Health (including Mental Health) for Global Societal Resilience”, delivered in the framework of the G7 process and calling for brain health to become a cross-cutting global policy priority. Signed by leading scientific academies from Canada, France, Germany, [...]
The Swiss Brain Health Foundation organised, in collaboration with the INECO Foundation and the International Alliance on Brain Health, a high-level meeting in conjunction with The Lancet Commission on Brain Health, which took place on 24 and 25 April 2026 in Buenos Aires. The event brought together leaders across neuroscience, psychiatry, public health, economics, and [...]
The Belgian Brain Council organised a roundtable at the European Parliament titled “Scientific Sovereignty as a Strategic Priority for Europe, with a Focus on Health and Brain Research” on 12 May 2026 in Brussels and online (hybrid format). Hosted by Tomislav Sokol, in collaboration with Université libre de Bruxelles, the event brought together a diverse [...]
Neurotechnology touches some of the most intimate dimensions of being human – cognition, behaviour, mental health, autonomy, identity. From brain implants restoring movement to consumer devices marketed for sleep and focus, it is reshaping healthcare and raising profound ethical questions at the same time. Europe is already the world’s second-largest neurotechnology market. But despite [...]
The European Brain Council is pleased to introduce the Seal of Responsible Neurotechnology, a voluntary ethical label to address unmet governance needs in the neurotechnology sector.Neurotechnology, encompassing devices and procedures that interact with the brain and nervous system, are increasingly deployed outside clinical settings, raising ethical questions about human agency, mental privacy and freedom of [...]
